Skip to Main Content
Contribute Try STAT+ Today

A group of Florida lawmakers is urging the U.S. Army to hold a hearing on its plan to give Sanofi an exclusive license to develop a Zika virus vaccine, a move that has raised concerns the product may be priced too high for many Americans, even though it was developed with taxpayer funds.

In a June 13 letter, eight U.S. House Democrats and one Republican expressed concern about the “potential for monopolistic practices that would, effectively, keep this life-saving vaccine out of reach for far too many of our constituents.” At the same time, U.S. Sen. Bill Nelson, who is also a Democrat, sent his own letter in which he urged the Army to limit the price for the vaccine.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.